Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 4Genitourinary 3Head & Neck 2Gynecologic 2CNS 2Thoracic 1Other 1Gastrointestinal 1Classical hematology 1

Conditions

Obesity 112Neoplasms 43Sexual Dysfunction, Physiological 31Polycystic Ovary Syndrome 27Overweight 18Breast Neoplasms 18Diabetes Mellitus 16Colorectal Neoplasms 16Dyspnea 14Diabetes Mellitus, Type 2 13Obesity, Morbid 12Mucositis 12Constipation 12Depression 11Prostatic Neoplasms 10Lung Neoplasms 10Hypertension 10Pulmonary Disease, Chronic Obstructive 9Non-alcoholic Fatty Liver Disease 9Metabolic Syndrome 9Insulin Resistance 9Motor Activity 8Cardiovascular Diseases 8Renal Insufficiency, Chronic 7Opioid-Induced Constipation 7Heart Failure 7Asthma 7Sarcopenia 6Rectal Neoplasms 6Multiple Myeloma 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Behavior × Other × Clear all
NCT00758108 2019-12-12

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

National Institutes of Health Clinical Center (CC)

Completed
197 enrolled
GenitourinaryOther

Behavior, Intellectual Disability, Wilms Tumor, Obesity, Urogenital Abnormalities, Aniridia, WAGR Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡